Effect of Surgical Treatment on Lipid Peroxidation Parameters and Antioxidant Status in the Serum of Patients with Peripheral Arterial Disease
Open Access
- 3 November 2013
- journal article
- research article
- Published by Wiley in Disease Markers
- Vol. 35 (6) , 647-652
Abstract
The various risk factors for peripheral arterial disease (PAD) are almost identical to those for atherosclerosis and include abnormal levels of lipids or lipoproteins. Lipid peroxidation parameters and total antioxidant capacity in the serum of male patients with PAD before surgery as well as 3–5 days and 7–10 days after surgery were measured. We also compared these parameters with those in a group of patients receiving simvastatin therapy. Concentrations of lipid hydroperoxides (LOOHs) and malondialdehyde, the total antioxidant capacity (assessed by ferric reducing antioxidant power assay), concentration of thiol (-SH) groups, and ceruloplasmin activity were determined spectrophotometrically in PAD patients treated surgically (Group I) or pharmacologically (Group II). The patients before surgical treatment had significantly higher concentrations of malondialdehyde but lower ceruloplasmin activity than those observed in Group II, treated with simvastatin. No significant differences before surgery in ferric reducing antioxidant power or thiol concentrations were found between the two groups. However, in Group I, both ferric reducing antioxidant power and thiol group concentrations decreased 3–5 days postoperatively, and ceruloplasmin activity increased 7–10 days after surgical treatment. The presented results demonstrate diverse oxidative stress responses to surgical treatment and confirm the beneficial effects of statin therapy in PAD.Keywords
This publication has 50 references indexed in Scilit:
- Use of statins in lower extremity artery disease: a reviewBMC Surgery, 2012
- Editorial The effects of statins on blood pressure: current knowledge and future perspectivesArchives of Medical Science, 2012
- Secondary Prevention and Mortality in Peripheral Artery DiseaseCirculation, 2011
- Novel markers of peripheral arterial diseaseVascular Medicine, 2009
- Vascular protection in peripheral artery disease: systematic review and modelling studyHeart, 2009
- Incidence of and factors associated with achieving target lipid levels in patients with peripheral arterial diseaseJournal of General Internal Medicine, 2006
- A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stressNutrition, Metabolism and Cardiovascular Diseases, 2005
- Effect of combined statin and beta-blocker treatment on one-year morbidity and mortality after acute myocardial infarction associated with heart failureThe American Journal of Cardiology, 2004
- Structure, oxidant activity, and cardiovascular mechanisms of human ceruloplasminLife Sciences, 1995
- Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophagesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993